TruAlt Bioenergy Limited approved additional investments totaling ₹29.69 crore in two of its subsidiaries during a board meeting held on September 22, 2026. The capital infusion aims to support the growth and expansion plans of Leafiniti Bioenergy Private Limited and TruAlt Sumi Gas Private Limited.

The board authorized an investment of ₹21.42 crore in Leafiniti Bioenergy Private Limited. This transaction involves the subscription of 2,14,20,000 equity shares at a par value of ₹10 each. The company currently holds 51% of the paid-up equity share capital in Leafiniti, and the proposed transaction is to be carried out on an arm's length basis.

Additionally, the board approved an investment of ₹8.27 crore in TruAlt Sumi Gas Private Limited (formerly TruAlt Gas Private Limited). This includes the acquisition of 24,31,830 equity shares with a face value of ₹10 each, priced at ₹34 per share, which includes a premium of ₹24 per share. TruAlt Bioenergy also holds a 51% stake in this entity.

Subsidiary Performance and Strategic Context

Leafiniti Bioenergy Private Limited, incorporated in February 2020, operates as a joint venture between TruAlt Bioenergy and GAIL India Limited. The subsidiary is engaged in the production and sale of compressed biogas and allied products such as Fermented Organic Manure (FOM) and Liquid Fermented Organic Manure (LFOM).

The following table details the revenue trajectory of Leafiniti over the last three financial years:

TruAlt Sumi Gas Private Limited, incorporated in September 2024, is a joint venture with Sumitomo Corporation, Japan. It is engaged in similar bioenergy activities but has not yet commenced operations; consequently, turnover details are not available.

Board Appointments and Governance Updates

The board appointed Dr. Sarvamangala R Patil as an Additional Director in the category of Non-Executive Independent (Woman) Director. She possesses over two decades of experience in biotechnology, academic leadership, and government advisory roles. Her appointment is subject to shareholder approval via a special resolution for a term of one year from September 22, 2026, to September 21, 2027.

To facilitate the postal ballot process for her confirmation, the board appointed Mr. Deepak Sadhu, a Practising Company Secretary, as the Scrutinizer. NSDL was appointed as the e-voting agency for the remote e-voting process.

What the Numbers Show

The significant year-on-year revenue jump in Leafiniti Bioenergy from ₹2,760.74 lakh in FY25 to ₹4,043.09 lakh in FY26 highlights rapid scaling in the compressed biogas segment. The decision to inject ₹21.42 crore at par value into this growing subsidiary suggests a strategic focus on consolidating control and funding capacity expansion without diluting existing equity value through premium issuance, contrasting with the premium-priced entry into the newer venture, TruAlt Sumi Gas.

TruAlt Bioenergy promoter group entity Nirani Holdings Private Limited (NHPL) acquired 50,000 equity shares on September 17, 2026. The open market purchase was executed through the National Stock Exchange of India Limited (NSE) at an average price of ₹424.64 per share.

The transaction value aggregated to ₹2,12,32,000. This acquisition increased NHPL’s stake in the company from 1.87% (16,07,411 shares) to 1.93% (16,57,411 shares).

Transaction Details

The disclosure was made under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Vijaykumar Nirani, Director of NHPL, signed the Form C declaration.

Regulatory Compliance

Monu Kumar, Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, submitted the disclosure to both the Bombay Stock Exchange and the National Stock Exchange. The filing confirms that the transaction was conducted on the open market and excludes taxes, brokerage, or other charges from the stated value.